Resources with keywords: covid-19
Guidance for Working with Human Specimens (Document)
University of Colorado
14 September 2021
Work with all human specimens must be conducted according to the appropriate containment and work practices.
SARS-CoV-2 and Biosafety in Laboratory (NEW 8/18, Document, Publication)
Iraqi JMS
15 August 2021
A Al-Shuwaika, et.al
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 (NEW 8/18, Website, Publication)
CDC/MMWR
13 August 2021
ARCHIVED: Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 (Website, Publication)
CDC/MMWR
13 August 2021
ARCHIVED: Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years — COVID-NET, 13 States, February–April 2021 (Website, Publication)
CDC/MMWR
13 August 2021
How Dangerous Is the Delta Variant (B.1.617.2)? (NEW 8/18, Website)
American Society for Microbiology (ASM)
30 July 2021
Discusses how contagious the Delta variant is, whether current vaccines protect against it and how dangerous it is.
COVID Data Tracker Weekly Review (Archived) (Website, Regulatory)
CDC Archive
May 11, 2023, marked the end of the federal COVID-19 public health emergency (PHE) declaration. This doesn’t mean that COVID-19 is over, but the end of the PHE did initiate a cascade of updates to COVID-19 data collection, reporting, and surveillance. Some surveillance metrics will remain the same, but some will change in terms of reporting frequency, data sources, or availability.
